XML 81 R62.htm IDEA: XBRL DOCUMENT
v3.26.1

EQUITY (Narrative) (Details) | 1 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | ---
Jan. 31, 2025 USD ($) $ / shares shares | Nov. 30, 2024 USD ($) $ / shares shares | Apr. 30, 2024 USD ($) $ / shares shares | Aug. 31, 2023 USD ($) $ / shares shares | Sep. 30, 2022 USD ($) $ / shares shares | Sep. 30, 2020 USD ($) shares | Dec. 31, 2025 USD ($) shares | Dec. 31, 2024 USD ($) | Dec. 31, 2023 Share ₪ / shares shares | Dec. 31, 2023 USD ($) | Dec. 31, 2025 ₪ / shares | Dec. 31, 2025 USD ($) Share shares | Dec. 31, 2024 ₪ / shares | Dec. 31, 2024 USD ($) Share
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value |  |  |  |  |  |  | $ 454,000 | $ 11,427,000 |  |  |  |  |  |
Share issue related cost |  |  |  |  |  |  | 702,000 | 669,000 |  | $ 0 |  |  |  |
Gross proceeds |  |  |  |  |  |  | $ 13,894,000 | $ 16,357,000 |  | $ 14,089,000 |  |  |  |
Remaining authorized unissued ordinary shares | shares |  |  |  |  |  |  |  |  |  |  |  | 233,400,000 |  |
Option outstanding | Share |  |  |  |  |  |  |  |  |  |  |  | 311,967,000 |  | 141,634,245
Weighted average contractual life |  |  |  |  |  |  | 8 years 8 months 4 days | 7 years 7 months 6 days |  |  |  |  |  |
Risk-free interest rate (%) |  |  |  |  |  |  | 4.00% | 4.00% |  | 4.00% |  |  |  |
Average standard deviation |  |  |  |  |  |  | 93.00% | 73.00% |  | 69.00% |  |  |  |
Remaining unrecognized deferred compensation expense |  |  |  |  |  |  | $ 1,200,000 |  |  |  |  |  |  |
Compensation cost |  |  |  |  |  |  | 1,871,000 | $ 2,811,000 |  | $ 3,742,000 |  |  |  |
Weighted average exercise price outstanding | ₪ / shares |  |  |  |  |  |  |  |  |  |  | ₪ 0.1 |  |  |
ADSs [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise Price Of Share Issued | $ / shares |  |  |  | $ 85.44 |  |  |  |  |  |  |  |  |  |
Share issue related cost |  |  |  | $ 900,000 |  |  |  |  |  |  |  |  |  |
Gross proceeds |  |  |  | $ 14,600,000 |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  | 170,728 |  |  |  |  |  |  |  |  |  |
ADSs [Member] | IFRS 15 [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share issue related cost |  |  |  | $ 700,000 |  |  |  |  |  |  |  |  |  |
Recognized as equity |  |  |  | $ 12,000,000 |  |  |  |  |  |  |  |  |  |
H C Wainwright And Co Llc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds |  |  |  |  |  |  |  | 9,200,000 |  |  |  |  |  |
Sale of stock | shares |  |  |  |  |  | 825,010 |  |  |  |  |  |  |  |
Aggregate offering price |  |  |  |  |  | $ 25,000,000 |  |  |  |  |  |  |  |
Percentage of commission on sales agreement |  |  |  |  |  | 3.00% |  |  |  |  |  |  |  |
H C Wainwright And Co Llc [Member] | ADSs [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross proceeds |  |  |  |  |  |  | $ 5,000,000 |  |  |  |  |  |  |
Sale of stock | shares |  |  |  |  |  |  | 772,264 |  |  |  |  |  |  |
2003 Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  |  |  |  | 326,757,000 |  |
Option vested and exercised |  |  |  |  |  |  | To date, each PSU grant has had between three to five performance goals on which vesting is based, each such goal being either a specified Company milestone and or the success of a specific project, with vesting of 20-40% on the achievement of each goal. |  |  |  |  |  |  |
Option vested |  |  |  |  |  |  | 8,787,600 |  |  |  |  |  |  |
Performance Shares Unit [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option outstanding | Share |  |  |  |  |  |  |  |  | 12,219,465 |  |  | 8,126,400 |  | 4,010,670
Weighted average exercise price outstanding | ₪ / shares |  |  |  |  |  |  |  |  | ₪ 0.1 |  | 0.1 |  | ₪ 0.1 |
Performance Shares Unit [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Option outstanding | Share |  |  |  |  |  |  |  |  |  |  |  | 21,240,000 |  |
Weighted average exercise price outstanding | ₪ / shares |  |  |  |  |  |  |  |  |  |  | 0 |  |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise Price Of Share Issued | $ / shares |  | $ 21.85 | $ 32 |  | $ 44 |  |  |  |  |  |  |  |  |
Amount allocated to warrant |  | $ 27,000 | $ 642,000 |  | $ 800,000 |  |  |  |  |  |  |  |  |
Change in fair value |  | $ 2,721,000 | $ 6,250,000 |  | $ 9,100,000 |  | $ 24,000 | 478,000 |  |  |  |  |  |
Risk-free interest rate (%) |  | 4.19% | 4.21% |  | 3.62% |  | 3.47% |  |  |  |  |  |  |
Average standard deviation |  | 84.50% | 84.70% |  | 82.50% |  | 101.32% |  |  |  |  |  |  |
Aggregate offering price |  | $ 9,000,000 | $ 6,000,000 |  |  |  |  |  |  |  |  |  |  |
Registered direct offerings sales | shares |  | 308,749 | 187,500 |  | 340,909 |  |  |  |  |  |  |  |  |
Warrants expiration period |  |  | five years |  | five years |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  | $ 32 |  | $ 46 |  |  |  |  |  |  |  |  |
Proceeds from warrant issue, net |  | $ 8,900,000 | $ 5,400,000 |  |  |  |  |  |  |  |  |  |  |
Warrant [Member] | Initial recognition [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of the warrants |  |  |  |  |  |  |  |  |  |  |  | $ 250,000 |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value |  |  |  |  |  |  | $ 5,571,000 | 298,000 |  |  |  |  |  |
Fair value of the warrants |  |  |  |  |  |  |  |  |  |  |  | $ 171,000 |  | $ 679,000
Risk-free interest rate (%) |  |  |  |  |  |  | 3.55% |  |  |  |  |  |  |
Average standard deviation |  |  |  |  |  |  | 94.00% |  |  |  |  |  |  |
Warrantt [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value |  |  |  |  |  |  | $ 102,000 | 745,000 |  |  |  |  |  |
Risk-free interest rate (%) |  |  |  |  |  |  | 3.55% |  |  |  |  |  |  |
Average standard deviation |  |  |  |  |  |  | 96.00% |  |  |  |  |  |  |
Pre Funded Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise Price Of Share Issued | $ / shares |  | $ 0.004 |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued to purchase shares | shares |  |  |  |  |  |  | 226,392 |  |  |  |  |  |  |
Warrants expiration period |  | four years |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  | $ 23.6 |  |  |  |  |  |  |  |  |  |  |  |
Changes In Fair Value Recorded As A Non-operating Income |  |  |  |  |  |  | $ 643,000 | $ 1,976,000 |  |  |  |  |  |
Beneficially Own In Excess |  | 4.99% |  |  |  |  |  |  |  |  |  |  |  |
Consultants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of shares issued | shares |  |  |  |  |  |  |  |  | 17,836,200 |  |  |  |  |
Weighted average exercise price | ₪ / shares |  |  |  |  |  |  |  |  | ₪ 0.36 |  |  |  |  |
Option vested and exercised |  |  |  |  |  |  | The options to consultants generally vest over four years and may be exercised for periods of between five and ten years. |  |  |  |  |  |  |
Option outstanding | Share |  |  |  |  |  |  |  |  |  |  |  | 14,790,000 |  |
Weighted average contractual life |  |  |  |  |  |  | 9 years 9 months 18 days |  |  |  |  |  |  |
Weighted average exercise price outstanding | ₪ / shares |  |  |  |  |  |  |  |  |  |  | ₪ 0.03 |  |  |
Investors [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued to purchase shares | shares |  | 205,893 | 187,500 |  | 340,909 |  |  |  |  |  |  |  |  |
Placement Agent's Designees [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amount allocated to warrant |  |  |  |  | $ 400,000 |  |  |  |  |  |  |  |  |
Aggregate offering price |  |  |  |  | $ 15,000,000 |  |  |  |  |  |  |  |  |
Warrants issued to purchase shares | shares |  |  |  |  | 17,045 |  |  |  |  |  |  |  |  |
Warrants expiration period |  |  |  |  | five years |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  | $ 55 |  |  |  |  |  |  |  |  |
Proceeds from warrant issue, net |  |  |  |  | $ 13,500,000 |  |  |  |  |  |  |  |  |
Highbridge Capital Management Llc [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise Price Of Share Issued | $ / shares |  | $ 21.86 |  |  |  |  |  |  |  |  |  |  |  |
Registered direct offerings sales | shares |  | 103,037 |  |  |  |  |  |  |  |  |  |  |  |
January 2025 Offering [Member] | ADSs [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise Price Of Share Issued | $ / shares | $ 8 |  |  |  |  |  |  |  |  |  |  |  |  |
Registered direct offerings sales | shares | 858,303 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued to purchase shares | shares | 1,250,000 |  |  |  |  |  |  |  |  |  |  |  |  |
January 2025 Offering [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Amount allocated to warrant | $ 700,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Change in fair value | $ 10,400,000 |  |  |  |  |  | $ 1,878,000 |  |  |  |  |  |  |
Risk-free interest rate (%) | 4.41% |  |  |  |  |  | 3.64% |  |  |  |  |  |  |
Average standard deviation | 90.20% |  |  |  |  |  | 91.00% |  |  |  |  |  |  |
Fair value of the ordinary warrants was adjusted amount | $ 1,400,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Changes In Fair Value Recorded As A Non-operating Income |  |  |  |  |  |  | $ 7,204,000 |  |  |  |  |  |  |
January 2025 Offering [Member] | Pre Funded Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise Price Of Share Issued | $ / shares | $ 7.996 |  |  |  |  |  |  |  |  |  |  |  |  |
Registered direct offerings sales | shares | 391,697 |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of other equity instruments exercisable | $ / shares | $ 0.004 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expiration period | five years |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares | $ 8 |  |  |  |  |  |  |  |  |  |  |  |  |
Beneficially Own In Excess | 4.99% |  |  |  |  |  |  |  |  |  |  |  |  |
January 2025 Offering [Member] | Pre Funded Warrants [Member] | Placement Agent [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from public offering, gross | $ 10,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued to purchase shares | shares | 62,500 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants expiration period | five years |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares | $ 10 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants offering consideration | $ 500,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds From Exercise Of Warrants After Deducting Fees And Expenses | $ 8,900,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of the warrants |  |  |  |  |  |  |  |  |  |  |  | $ 2,174,000 |  |
Warrants issued to purchase shares | shares |  |  |  |  |  |  | 63,636 |  |  |  |  |  |  |

X
- Definition Aggregate offering price. + References No definition available. + Details
Name: | blrx_AggregateOfferingPrice
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount allocated to warrant. + References No definition available. + Details
Name: | blrx_AmountAllocatedToWarrant
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Beneficially Own In Excess + References No definition available. + Details
Name: | blrx_BeneficiallyOwnInExcess
Namespace Prefix: | blrx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. + References No definition available. + Details
Name: | blrx_ChangesInFairValueRecordedAsANonoperatingIncome
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise price of shares issued. + References No definition available. + Details
Name: | blrx_ExercisePriceOfShareIssued
Namespace Prefix: | blrx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Exercise price of warrants. + References No definition available. + Details
Name: | blrx_ExercisePriceOfWarrants
Namespace Prefix: | blrx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents amount fair value of ordinary warrants adjusted. + References No definition available. + Details
Name: | blrx_FairValueOfOrdinaryWarrantsAdjustedAmount
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of commission on sales agreement. + References No definition available. + Details
Name: | blrx_PercentageOfCommissionOnSalesAgreement
Namespace Prefix: | blrx_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents amount of proceeds from exercise of warrants after deducting fees and expenses. + References No definition available. + Details
Name: | blrx_ProceedsFromExerciseOfWarrantsAfterDeductingFeesAndExpenses
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Proceeds from public offering. + References No definition available. + Details
Name: | blrx_ProceedsFromIssuanceOfInitialPublicOffering
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Proceeds from warrant issue. + References No definition available. + Details
Name: | blrx_ProceedsFromWarrantIssue
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of recognized as equity Pursuant to IFRS 15. + References No definition available. + Details
Name: | blrx_RecognizedAsEquity
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Remaining authorized unissued ordinary shares. + References No definition available. + Details
Name: | blrx_RemainingAuthorizedUnissuedOrdinaryShares
Namespace Prefix: | blrx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Remaining unrecognized deferred compensation expense. + References No definition available. + Details
Name: | blrx_RemainingUnrecognizedDeferredCompensationExpense
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sale of stock. + References No definition available. + Details
Name: | blrx_SaleOfStockNumberOfSharesIssued
Namespace Prefix: | blrx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Registered direct offerings sales. + References No definition available. + Details
Name: | blrx_SharesIssuedRegisteredDirectOfferings
Namespace Prefix: | blrx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tha amount of warrant offering consideration. + References No definition available. + Details
Name: | blrx_WarrantOfferingConsideration
Namespace Prefix: | blrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Warrants expiration period. + References No definition available. + Details
Name: | blrx_WarrantsExpirationPeriod
Namespace Prefix: | blrx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants issued to purchase shares. + References No definition available. + Details
Name: | blrx_WarrantsIssuedToPurchaseShares
Namespace Prefix: | blrx_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Types of share-based payment arrangements [domain]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_a&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_a&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_FinancialLiabilitiesAtFairValue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_GainsLossesOnChangeInFairValueOfDerivatives
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2025-01-01 -Paragraph 17 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 227 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 227 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_227&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_KeyManagementPersonnelCompensation
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of share options outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard -URIDate 2025-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard -URIDate 2025-03-27 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from issuing shares. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProceedsFromIssuingShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ShareIssueRelatedCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) exercisable in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_ii&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_ii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard -URIDate 2025-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard -URIDate 2025-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard -URIDate 2025-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 31 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=blrx_AmericanDepositarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_InitiallyAppliedIFRSsAxis=ifrs-full_IncreaseDecreaseDueToApplicationOfIFRS15Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=blrx_HCWainwrightAndCoLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=blrx_ShareIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=blrx_PerformanceSharesUnitMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=blrx_PerformanceSharesUnitTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=blrx_WarrantFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtFairValueThroughProfitOrLossDesignatedUponInitialRecognitionCategoryMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=blrx_WarrantFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=blrx_WarrantSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=blrx_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfInvestmentPropertyAxis=blrx_ConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfInvestmentPropertyAxis=blrx_InvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfInvestmentPropertyAxis=blrx_PlacementAgentsDesigneesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfInvestmentPropertyAxis=blrx_HighbridgeCapitalManagementLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfInvestmentPropertyAxis=blrx_January2025OfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=blrx_WarrantOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=blrx_PlacementAgentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |